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Specific inhibition of the immune response has been achieved by two different 
procedures,  acting  presumably by different mechanisms.  Acquired  immuno- 
logical tolerance or immunological paralysis is induced in certain experimental 
situations by the introduction of antigen. A  similar non-responsiveness may 
result from the passive transfer of specific antibodies prior to antigen injection. 
Although there are certain s~milarities between tolerance and antibody-induced 
inhibition of the immune response, such as the requirement for the continuous 
presence of the inductive agent (antigen and antibody, respectively) they are 
clearly distinguished by fundamental differences in the status of the immuno- 
logical system in the treated hosts. Transfer of lymphoid cells  from  tolerant 
animals to  immunologically incompetent recipients does not lead to  an im- 
mediate regain of immunological reactivity against the specific  antigens (for 
discussion see reference  1),  whereas  similar passage  of cells  from antibody- 
treated to untreated hosts results in normal antibody synthesis (2) upon sub- 
sequent injection of the corresponding antigen. 
Inhibition of the humoral component  of the immune response by passively  ad- 
ministered  antibodies  has been demonstrated in a  variety of experimental  systems 
using particulate antigens,  such  as viruses, bacteria,  red cells and nucleated  tissue 
cells, and soluble antigens, such as bacterial toxins as well (for references, see reference 
3). In isoantigenic systems of the H-2 type in mice, both the humoral and the cell- 
bound immune response could be inhibited in this way, leading to dramatic changes 
of the transplantation behavior of normal and neoplastic tissues (immunological en- 
hancement)  (4, 5). 
The antibody-mediated  inhibition of the immune response may reveal the existence 
of a feed-back system regulating the level of antibody synthesis with regard to a given 
antigen. Several hypotheses have been put forward concerning the mechanism involved 
(6--10). According to one of them antibodies  inhibit the immunological capacity of 
the antibody-producing cells specifically and directly (central inhibition of the immune 
response). This hypothesis was based on the fact that efficient inhibition could be ob- 
tained during the first 3 to 6 days after the antigen (8). However, other findings sug- 
gested that the antibodies acted primarily at the antigenic level (afferent inhibition) 
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by combining with the antigenic determinants and thus resulted in the suppression 
of the induction of the immune response (2, 9,  11).  In transplantation system this 
mechanism of antibody action resulted in efferent inhibition of the homograft reaction 
in addition, since antibody-coated cells were protected from destruction by immune 
lymphoid ceils (2, 9). 
The present investigation represents an attempt to study the mechanism(s) 
by which passively transferred antibodies suppress antibody production. The 
Jerne method was applied (12) to study the antibody production of individual 
cells against sheep red cells in vitro. Particular interest was focused on the effect 
of passively transferred antibodies given at various intervals after antigen injec- 
tion. The inhibiting capacity of purified 19S and 7S antibodies has been investi- 
gated separately. Also, the effect of passively transferred antibodies on 19S and 
7S production was examined, in an attempt to clarify some of the factors in- 
volved in the regulation of antibody synthesis. 
Materials and Methods 
Mixe of the following inbred strains were used;  A/SnK1,  A.CA/K1,  A.BY/K1,  A.SW/KI, 
C3H/K1,  C57BL/K1,  C57L/K1, and CBA/K1.  Some  experiments  were  performed with  F1 
hybrids of two of these strains. Within each experiment all mice were of the same sex and age. 
The mice were bred and kept in accordance with procedures worked out in our laboratory (13). 
Antibod/es were produced by intraperitoneal injections of 4 X  10  a sheep red cells. The ani- 
mals were bled at various intervals depending on the type of antibody required. When high 
titers of 19S antibodies were needed, they were bled after 5 days; i.e., the time of maximal 19S 
production in this system. 7S antibodies were derived from hyperimmune sera collected after 
at least 2 but usually up to 7 weekly intraperitoneal injections of 4 X  108 sheep red cells; the 
mice were bled 5 to 6 days after the last injection. However, all antisera were separated into 
19S and 7S components  by sephadex G-200 gel filtration before  they were  used in the ex- 
periments. 
Serological Procedures.--Agglutination was performed  in  the presence  of polyvinylpyr- 
rolidone (PVP) and hemolysis in the presence of guinea pig serum as a source of complement 
(13). 
Antibody Fracgonagon into 7S and  19S components  was  performed  by sephadex  G-200 
gel filtration (13). 
The Agar Plaque Technique for detection of individual antibody-producing cells in vitro 
was performed according to the method of Jerne (12). 
Inhibigon Experim~ts.--Each mouse was given 0.1 ml of a sheep red cell suspension con- 
taining 4 X  10  s cells intraperitoneally  or intravenously. 0.1 ml mouse anti-sheep red cell serum 
was injected 2 hours to 15 minutes before the red cells or 1, 2, 3, or 4 days later. 
In experiments designed to test the inhibiting capacity of purified  19S and 7S antibodies, 
analogous procedures were used and fractions isolated from 0.1 to 0.3 ml whole serum were 
injected into each recipient prior to the red cells. In some of these experiments 20 times fewer 
red cells (2 X  107) were injected to each recipient and the antibody fractions were obtained 
from 1 to 2 ml serum. 
RESULTS 
Antibody-Induced Inhibition of the Plaque-Forming  Ability of Spleen Cells.- 
Plaque-forming  cells  (PFC)  in  mouse  spleens  started  to  increase  in  number C~RAN  MOLLER  AND  HANS  WIGZELL  971 
about 24 hours after the injection of sheep red cells, and rose exponentially dur- 
ing the subsequent 3 to 6 days, depending on the mouse strain and the antigen 
dose (see reference 13). Thereafter, the number of PFC decreased rapidly, but 
significant numbers were still present after 18 days (for a typical example, see 
Fig. 3). The increase in the number of plaque-forming cells  was paralleled by 
the increase of the hemolytically efficient, 2-mercaptoethanol(2-ME) sensitive, 
19S antibodies, whereas the decrease in the number of PFC, occurring 4 to 5 
days after injection of the antigen coincided in time with the appearance of 
7S,  2-ME  resistant  antibodies,  detectable  by  agglutination and,  to  a  lesser 
degree also by hemolysis. The hemolytic plaque technique thus offered possi- 
bilities  to  study the  effect of passively transferred antibodies  on individual 
lymphoid cells producing 19S  antibodies. 
As a  first test the effect of passively transferred antibodies given prior to the antigen was 
studied. Several such experiments were performed in various mouse strains. 0.05 to 0.2 ml 
hyperimmune  mouse  anti-sheep red cell serum of different  titers were injected 15 minutes  to 2 
hours before  the injection  of 4 X 10  s sheep red cells. In some experiments  the sheep red cells 
were treated with high titered antiserum in vitro and washed several times prior to injection. 
Similar results were obtained  with both procedures and they will be reported together. 
It was regularly found that passively transferred anti-sheep red cell antibodies 
prior to the injection of sheep red cells caused a pronounced inhibition of the 
number of PFC during the entire test period (8 days) (Table I). Usually the 
number of PFC was the same during the entire period as in the non-injected 
controls (0 to 100 plaques per spleen), but occasionally even lower numbers were 
found. Recipients not exposed  to antibody formed 3.000  to  200.000  plaques 
per spleen 4 to 5 days after antigen injection. 
In some experiments with weak sera the inhibition was not complete. It was 
usually found that the suppression of the number of plaque-forming cells de- 
creased with lower antibody doses (Table I, experiments 5 and 6) (Fig. 1). This 
was revealed by a lower maximum number of PFC at days 4 and 5. In some 
experiments very low antibody doses (0.01  to 1 #1) caused an increase in the 
number  of  PFC  compared  to  the  non-antibody-treated controls.  One such 
experiment is illustrated in Fig. 1. At present it is not known what the condi- 
tions are for this effect to occur. 
Number of PFC after Passive Antibody Transfer Following Antigen Adminis- 
tration.--The  demonstration that antibodies injected prior to the antigen, or 
directly absorbed onto the sheep red cells, were capable of depressing the num- 
ber of antibody-producing cells is in agreement with previous findings in other 
experimental systems (2, 11). Various experiments outlined in the introduction 
led to the conclusion that antibodies inhibited the immune response primarily 
by combining with the antigenic determinants. Other findings obtained by Brent 
and  Medawar  (8)  suggested,  however,  that  antibodies  inhibited  antibody 
formation directly at the cellular level, since they were capable of acting after 972  ANTIBODY  SYNTHESIS  AT  CELLULAR  LEVEL 
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the  homograft  reaction  had  been  already  initiated.  This  problem  was  now 
reinvestigated by the hemolytic plaque technique, which permits a study at the 
cellular level. 
As a first step, antibodies were transferred passively 1, 2, 3, and 4 days after the intravenous 
administration of sheep cells and the number of PFC was determined on day 4. The antiserum- 
treated groups received 0.1 ml of a hyperimmune mouse anti-sheep red cell serum (agglutinin 
titer 3s). A control group received the antigen only. On day 4 (3 hours after the last antiserum 
injection) the mice were killed and the number of PFC determined. 
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FIG. 1. Effect of various doses of mouse anti-sheep red cell serum injected at the same day 
as the antigen on the number of plaque-forming spleen cells 4 days later in  (A X  CBA)  F1 
mice (experiment A) and in A.CA mice (experiment B). Each bar represents the mean value 
of 4 mice. 
As illustrated in Fig. 2 there was a  marked decrease in the number of PFC 
if antibodies were given 1 and 2 days after the antigen. Antiserum given 3 and 
4  days after  the  antigen  (less  than  40 hours  before  testing)  had  a  negligible 
effect only. 
A  more detailed study with a  similar purpose was subsequently undertaken 
by injecting groups of 8 to 20 mice with sheep red cells followed by antibodies 
at various intervals.  Starting the 2nd day after antigen injection,  2 non-anti- 
body-injected controls and 2 antibody-treated mice of each group were killed 
and  the  number  of PFC  determined.  Different  experiments  performed  with 976  ANTIBODY SYNTHESIS AT CELLULAR  LEVEL 
different mouse strains gave similar results, two of which are illustrated in Figs. 
3 a and 3 b. Antibodies given 1 hour after the antigen caused a complete sup- 
pression of PFC. The effect of passively transferred antibodies given after 1 to 4 
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FIG. 2. Number of PFC in CBA mice 4 days after the injection of sheep red cells. One group 
remained untreated, whereas the others were given mouse anti-sheep red cell serum at the 
indicated days. Each bar represents the mean value of 4 mice. 
days was manifested after a  latency period of 48 hours as the termination of 
the exponential increase in PFC numbers. In no case did the injected antibodies 
detectably inhibit the increase of PFC numbers during the  first 24 hours. The 
interval of 48 hours before the observable effect of passively transferred anti- 
bodies was the same whether the antibodies were administered 1, 2, or 3, days 10  4 
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FIGS. 3 a and 3 b. Development of plaque-forming spleen cells in A.BY mice (Fig. 3 a) and 
(A X  C3H)F1 hybrids (Fig. 3 b) after injection with sheep red cells alone or followed by mouse 
anti-sheep serum at the indicated days. Each point represents the mean value of 2 mice. 
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after the antigen. Subsequent to the end of the exponential phase the number 
of PFC in the antibody-treated animals decreased at the same rate as the non- 
antibody-treated controls after the peak day. 
A few experimentswereperformed  to study more precisely the time needed for 
passively transferred antibodies to inhibit the appearance of the PFC. A typical 
experiment is illustrated in Fig. 4, where anti-sheep red cell antibodies were 
injected 24 hours after the antigen and the number of plaque-forming cells was 
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FIG. 4. Development of plaque-forming spleen ceils in A.BY mice at various times after 
the injection of sheep red cells alone or sheep red cells followed  by antiserum 24 hours later. 
Each point represents the mean value of 4 mice. The range is indicated by vertical bars. 
determined at 16, 40, and 50 hours thereafter. Spleen cells removed after 16 and 
40  hours  contained the  same  number  of PFC  as  the  non-antibody-treated 
controls, whereas a pronounced difference was found after 50 hours. 
The doubling time of PFC numbers during the exponential phase varied be- 
tween 5 and 12 hours in different experiments. On basis of the hypothesis (13) 
that cellular proliferation is mainly responsible for this increase it follows that 
3 to 8 cell divisions occurred in the presence of antibodies without any detectable 
inhibition. It would follow that antibodies did not inhibit the antibody synthesis 
of already committed cells directly. It seems more likely that they counteracted 
the stimulus inducing the cell divisions responsible for the increase in the num- 
ber of PFC, although this was not manifested during the first 40 hours. 
Inhibiting Effect  of 19S and  7S Antibodies.--In  the  experiments described 
above, whole serum was used as a source of antibodies. It is of importance to GORAN MOLLER AND  HANS WIGZELL  979 
determine what type of antibody is responsible for the inhibition of PFC forma- 
tion. As a first step the effect of purified 19S and 7S antibodies was tested. The 
antibody fractions were prepared by sephadex G-200  gel filtration (13).  The 
19S  fractions were  tested for possible contamination with  7S  antibodies by 
treating samples of the pooled and concentrated fractions with 2-ME and there- 
after testing for residual agglutinln activity. In no cases were 2-ME resistant 
7S agglutinins detected in the 19S fractions. 
Concentrated fractions derived from 0.1 to 0.2 ml mouse anti-sheep red cell sera were in- 
jected intraperitonenlly  30 minutes  prior to the injection  of the sheep red ceLls.  Control  groups 
received sheep red ceils only. Four days later the spleens of the recipients were tested by the 
Jeme method. Four experiments  of this design  were performed in different  mouse  strains and 
they a11 had similar results. 
As can be seen from Table H  (experiments 1 to 4)  7S antibodies caused a 
pronounced suppression of the number of PFC, whereas 19S antibodies were 
much less efficient. The source of the antibodies did not appear to influence the 
results, since the findings were the same whether the 19S antibodies were iso- 
lated from hyperimmune sera or from the sera of mice given a first antigen in- 
jection 5 days previously. Even in cases (experiment 3) where the agglutinin 
titers of the 19S and 7S fractions were the same and the hemolytic titers of 19S 
therefore considerably higher,  only the  7S  antibodies inhibited the immune 
response. 
It seemed possible, however, that this difference between 19S and 7S anti- 
bodies was quantitative rather than qualitative. It has been reported that the 
agglutinating and hemolytic efficiency of 19S  antibodies  is  relatively higher 
than their precipitating activity, whereas this was not the case with 7S anti- 
bodies (14). 
In an attempt to detect a possible suppressing effect of 19S antibodies on the 
immune response,  analogous experiments were performed,  but  the antibody 
fractions injected were derived from sera with higher titers and larger volume 
(0.25 to 1 ml) were used per recipient (experiments 5 and 6, Table II). The sheep 
red cell dose was decreased from 4 ×  10  s to 2 X  107 (experiments 7 to 11). This 
means a 100- to 200-fold increase of the antibody/antigen ratio. Several experi- 
ments of this type were performed as described previously (Table II, experi- 
ments 5 to 11) (Fig. 5). As shown in Table II, 19S antibodies were capable of 
inhibiting  the  appearance  of  PFC.  The  degree  of  inhibition  varied  in 
different experiments and was usually somewhat smaller than with 7S. How- 
ever, in experiments 7, 8, and 9,  19S and 7S inhibited to approximately the 
same degree. In experiment 9 the serum was taken 5 days after the first antigen 
injection, when 19S antibodies had reached their maximum value, whereas only 
smaU amounts of 7S were produced. This experiment makes it very unlikely 
that 7S contamination of the 19S fraction was responsible for the inhibition, 
since the purified fractions were of equal efficiency. 980  ANTIBODY  SYNTHESIS  AT  CELLULAR  LEVEL 
TABLE  II 
Inhibition  of the Plaque-Forming  Ability of Spleen  Cells by Purified 19S and  7S  Antibodies 
Given Prior to the Antigen Injection 
Exp.  Mouse strain  No. 
1  (A X  C3H)F~ 
2  (A X  C3H)Fx 
g6 
3  (A X  C3H)FI 
4  A.BY 
Antiserum 
No.  No. of 
of  sheep rccl  " 
mice  cells  Vol.  Frac-  Titers*  tion 
4  4X  los  --  --  -- 
4  "  O. 1  19S  O~ 
1/64~ 
4  "  0.1  7S  1/32~ 
1/16~t 
1  .... 
3  4X  l0  s  --  --  -- 
3  "  0.1  19S  1/8 
1/256 
3  "  0.1  7s  1/512 
1/32 
1  .... 
3  4X  los  --  --  -- 
3  "  0.2  19S  1/8 
1/5ooo 
3  4Xlos  0.2  7s  1/8 
1/4 
1  --  --  -- 
3  4X  los  --  --  -- 
3  "  0.1  19S  1/128 
1/512 
Mean No. and  Mean No. and 
range of PFC  range of PFC 
per spleen at  per I0  s spleen 
4 days  cells  at 4 days 
32500  197.7 
20000-55000  125.6-254.~ 
21875  237.0 
11000-3750C  125.1)-468.8 
8363  37.2 
3300-1600q  29.5-65.8 
0  0 
13733 
10000-2070G 
10617  100.4 
4350-1380C  49.4--137.13 
76.7  O. 54 
25-105  0.21--0.93 
5  0.08 
38700  203.3 
33100-432~  191.3-213.1 
20633  175.2 
14700-252~  142.9-210.13 
383  2.9 
275-440  2.4--3.4 
88  1.3 
3395 
1935-5250 
3482 
3145-3750 
45 
* The first titer refers to agglutination, the second to hemolysis in the presence of guinea 
pig complement. In experiments I0 and  11  only hemolytic titers were determined.  Unless 
indicated otherwise the titers refer to the peak 195 and 7S fractions after sephadex gel fil- 
tration. 
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TABLE  II---Uontinued 
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Exp. 
No.  Mouse strain 
No.  No. of 
of  shee~,red 
mice  ceus 
Antiserum 
Frac-  Titers*  Vol.  tion 
(A X  A.CA)FI  3  4  X  10  8  --  1  __ 
"  3  "  0.3  19S  1/160 
Mean No. and  Mean No. and 
range of PFC  range of PFC 
per spleen at  per 10  s spleen 
4 days  cells at 4 days 
2967  36.1 
1150-4050  30.5--44.0 
765  9.7 
A.CA 
A.SW 
A.SW 
1/2500  540-1040 
3  "  0.3  7S  1/2500 
1/lO 
3  4X  108  --  --  -- 
3  "  1.0  19S  1/128 
7.8-10.4 
392  4.2 
290-500  2.8--6.3 
34900 
157(D-47760 
12767 
1/1024  9400-16250 
1  m  m  __ 
4  2X  107  --  --  -- 
4  "  0.25  19S  1/64 
1/256 
4  "  0.25  7S  1/256 
1/64 
3  2X  107  --  -- 
4  "  0.5  19S  1/16 
1/256 
4  "  0.5  7S  1/5000 
1/32 
"  4 
(AXC.3H)Fx  4  2X  10  ~,  -- 
"  3 
"  4 
1.0  19S  1/325 
1/5000: 
1.0  7S  1/165 
1/165 
60 
1999 
900-4880 
41 
15-50 
2.5 
0-20 
30 
1650 
1150-2300 
33.2 
10-58 
5.0 
0-20 
16.5 
5-35 
3568 
1025--6540 
286. ? 
10-450 
285.0 
150-420 982  ANTIBODY SYNTHESIS AT CELLULAR LEVEL 
TABLE H--Concluded 
ENX~o~  Mouse  strain 
9,  (A X  C3H)F~ 
con't 
10  A.SW 
~c 
¢c 
lc 
cl 
c~ 
11  A.SW 
No.  No. of 
of  sheep red 
mice  cells 
1 
Ant~erum 
3  2X  107 
3 
3 
Frac- 
Vol.  tion  Titers* 
4  2X  107  --  --  -- 
2  "  19S  1/2565 
3  ....  1/128~ 
3  ....  1/64~ 
3  "  7S  1/16~ 
3  ....  1/8~ 
3  ....  1/4~ 
3  ....  1/2~ 
0.5  19S  1/81~ 
0.5  7s  ~/3~ 
Mean No. and  Mean No. and 
range of PFC  range of PFC 
per splee~ at  per l0 s spleeo 
4 days  cells at 4 days 
2O 
125.0 
51.0-179.( 
0.24 
0.23-0.24 
1.8 
0.78-3.75 
25.3 
11.9--42.0 
0.0 
0-0.1 
0.4 
0-1.3 
0.9 
0.2-2.0 
2.3 
0.45-6.5 
49.0 
32.0-75.0 
16.2 
1.5--31.0 
3.6 
1.6-6.7 
The inhibiting effect of various doses of 19S and 7S antibodies was studied 
quantitatively. As illustrated in Fig. 5 the degree of inhibition decreased with 
diminishing antibody doses; in the case of the higher dilutions of 19S, 1/25 and 
1/125 became actually stimulating, as compared to non-antibody-treated con- 
trols. A comparison between the hemolytic serum titers and the degree of PFC 
suppression indicated that  7S antibodies were about  115  times more efficient 
than 19S antibodies at all dilutions. 
Thus, it would appear that both 19S and 7S antibodies are both competent 
to  inhibit  the  appearance  of  antibody-producing  cells,  although  there  is  a 
marked difference in the relative efficiency of the two antibody types, 7S being 
about 100 to 200 times more efficient when compared on the basis of the same 
hemolytic titers. 
Antibody-Induced Inhibition of the 7S Response.--The previous studies have 
been concerned with antibody-induced depression of the PFC, as detected by 
the Jerne technique.  As shown (13)  the plaque-forming ability is presumably 
related  to  19S  antibody  production  whereas  the  marked  increase  in  2-ME GOKAN  M(SLLER AND  HANS  WIGZELL  983 
resistant 7S antibodies occurring after 5 to 7 days is not manifested in an in- 
crease of PFC. On the contrary the PFC decrease coincided with an increase 
of 7S production. Since passively transferred 7S antibodies had a marked ca- 
17~  7S-treated  recipients 
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FIa. 5. Effect of various doses 19S and 7S antibodies in  A.SW mice given at  the same day 
as the antigen on the number of plaque-forming cells per 10  6 spleen cells 4 days later, as related 
to the number found in non-antibody-treated recipients. Each bar represents the mean value 
of 3 mice. 
pacity to inhibit 19S synthesis, it seemed possible that actively produced 7S 
would also inhibit 19S formation. It is noteworthy, however, that 7S synthesis 
did not appear to be self-inhibiting immediately, since 7S  titers continued to 
increase during the first 12 to 20 days. As a first attempt to analyze the possible 
absence of such a 7S self-inhibition, it was investigated whether passively trans- 
ferred  antibodies  can  inhibit  7S  production  in  a  manner  analogous  to  the 
previously studied 19S synthesis. titer 
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Fins. 6 a  and 6 b. Production of 2-ME resistant 7S  anti-sheep agglutinins in  A.SW mice 
(Fig. 6 a) and A mice (Fig. 6 b) injected with sheep red cells alone or with red cells followed 
by antiserum at various intervals. The arrows indicate the time of antiserum injection. Each 
point represents the geometric mean titer of 3 mice. 
FIG. 6 a. 7S agglutinin titers after injection of sheep red cells alone and red cells followed by 
antiserum at the indicated days. 
FIG. 6 b. 7S titers after injection of sheep red cells alone and red cells followed by antiserum 
at the indicated days. 
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0.1 to 0.3 ml hyperimmune mouse anti-sheep red cell serum was injected 30 minutes prior 
to the intraperitoneal injection of 4  X  10  a sheep red ceils.  A control group received red cells 
only. At various intervals the number of PFC and the production of hemolytic antibodies was 
studied as in the previous experiments, and,  in addition, the titers of agglutinating antibodies 
were determined before and after 2-ME treatment.  Antibody treatment of the recipients re- 
snlted in complete suppression of PFC in accordance with the previous results, indicating that 
there was an efficient inhibition of 19S production. The results reported below will be concerned 
only with the effect of passively transferred antibodies on the synthesis of 2-ME resistant 7S 
agglutinins. 
As illustrated in Figs.  6 a and 6 b active production of 7S agglutinins was 
completely suppressed  by passively transferred  antibodies  given  before the 
antigen, and only the decay of the administered antibodies was observed. Sup- 
pression was complete during the entire test period (27 days). This is in agree- 
ment with previous results obtained with bacterial antigens and cellular  iso- 
antigens of the H-2 system in mice (2, 3, 5). 
Further studies indicated that passive transfer of antibodies within the first 
24 hours after injection of sheep red cells equally well suppressed 7S antibody 
production  (Figs.  6 a  and 6 b) in analogy with the results on 19S antibody 
systhesis. Twenty-four hours after injection the sheep red ceils have localized 
intracellularly in the spleen and liver,  as shown by studies with Cr  n- labeled 
cells (13), and 19S synthesis has been initiated. 
As a  further  step it was investigated whether antibodies given at various 
intervals after the antigen would suppress 7S antibody synthesis. Several differ- 
ent experiments were performed. In most cases simultaneous determinations of 
PFC, hemolytic antibody titers, and agglutinating titers before and after 2-ME 
treatment  were determined,  but in  some only agglutinins  were tested after 
treatment with 2-ME. 
It was found that antibodies given at the 3rd day after the antigen injection 
caused a  delayed production of 7S agglutinln~  (Figs.  6 a and 6 b). However, 
antibodies given at the 5th day or later, at the beginning of detectable 7S anti- 
body production,  did not  decrease the  subsequent active production  of  7S 
agglutinins and the titers in this group were identical to those obtained in non- 
antibody-treated controls (Figs. 6 a and 6 b). 
DISCUSSION 
As reported above, passively transferred anti-sheep red cell antibodies in- 
hibited completely the development of the PFC if given before the antigen. 
Antibody-induced suppression of the appearance of PFC was achieved also after 
antibody synthesis had been initiated,  although  a  detectable  effect was not 
observed before 40 hours after the antibody transfer. The mechanism by which 
antibodies suppress the immune response is not known as yet. Similar  studies 
in transplantation  systems involving the H-2 system of the mouse led to the 
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determinants and not by suppressing directly the antibody production of the 
immunologically  competent cells. The present findings substantiate this con- 
clusion by demonstrating that passively transferred antibodies did not directly 
inhibit the antibody synthesis of already producing  cells. There is at present 
little evidence to exclude the possibility that passively administered antibodies 
inhibit the immune response by interacting with the antigenic determinants 
(afferent inhibition).  If so, it follows from the present findings that this inter- 
action can also occur with intracellularly localized antigens,  since antibodies 
were efficient during the first 3 to 4 days after antigen injection as well. 
Evidence has been presented by Uhr and Finkelstein (15) suggesting that the 
presence of antigen is essential for the continuous synthesis of 19S antibodies. 
Passively transferred antibodies would presumably lead to a functional inacti- 
vation of the antigen and would be expected, therefore, to terminate 19S anti- 
body  production  at  any  stage  after its  initiation. Since passive  antibody 
transfer only led to inhibition of 19S antibody synthesis after a latency period 
of 40 hours, however, it would follow from the above concept that the presence 
of antigen is not a necessary requisite for antibody production by already com- 
mitted cells. However,  the presence of antigen appears  to be essential for the 
continuous increase  in PFC numbers,  presumably due to cell divisions. It is 
not known as yet, whether the sheep red cell antigens are present in the PFC or 
remain localized in other cell  types, such  as  macrophages,  where  they are 
initially taken up. It has been claimed, however, that flagellar antigens of bac- 
teria could not be found in the antibody-producing cells (16). If this is true for 
sheep red cell antigens  as well, it would follow that an antigen localized in  some 
other cell types would be responsible for the  stimulation leading  to cellular 
multiplication  of  the  19S  antibody-producing  cells. Passively  transferred 
antibodies  would interact with  the antigen and terminate this  stimulation. 
The fact that inhibition did not become expressed until 3 to 7 cell divisions had 
occurred could be ascribed to inefficient interaction between the antibodies and 
the antigen, or alternatively, to a lifetime of approximately 40 hours of the spe- 
cific stimulation factors. 
Although both 7S and 19S antibodies were capable of inhibiting the produc- 
tion of PFC, the efficiency of 7S antibodies was about 100 to 200 times greater 
when compared  at the same hemolytic titers. The difference in efficiency be- 
tween the two antibody types could not be adequately explained by reference 
to differences in avidity, which appeared to be of the same order of magnitude 
for a given serum (17). It seems possible, however, that 19S antibodies were 
more efficient on a molecular basis compared to 7S antibodies,  with regard to 
serological reactions in vitro, such as agglutination and, in particular hemolysis 
(13).  Inhibition of the immune response  presumably depends  on  the  satu- 
ration of the antigenic determinants (5). Therefore,  the number of 19S  and 
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ferent, resulting  in unequal degrees of inhibition,  since relatively fewer 19S 
antibody molecules would then be present. 
The termination of the 19S antibody production coincided in time with the 
appearance  of  7S  antibodies  in  the  serum  of  the  mice.  This  raised  the 
possibility that 7S antibodies might have inhibited the further development of 
19S antibody producing cells. Although alternative explanations do exist, such 
as a predetermined, limited lifetime of 19S antibody production, or depletion of 
antigen, the present findings on antibody-mediated inhibition of 19S antibody 
synthesis are in agreement with the possibility that 7S antibodies inhibit  19S 
antibody production. This possibility raises in turn the question why 7S anti- 
bodies do not inhibit their own production. This cannot be explained by any 
inherent inability of 7S to suppress the initiation of 7S production, since passive 
transfer of anti-sheep red cell serum within  24 hours after the antigen  injec- 
tion suppressed completely the production of 2-ME resistant 7S agglutinlns.  As 
previously discussed, antibodies did not appear to inhibit antibody synthesis in 
already committed cells, but seemed to act by removing the stimulus for the 
cell  divisions.  The absence of an immediate  self-lnhlbition  of 7S production 
could be satisfactorily explained by the assumption that 7S-producing  cells do 
not divide or divide at a slow rate. It is presently not possible to decide whether 
7S-producing  cells represent the end product of 19S synthesizing precursor cells, 
or two cell lines develop in parallel,  one responsible for 19S and one for 7S syn- 
thesis. Recent studies by Nossal (18) favor the former alternative. The present 
data would be in agreement with this possibility. According  to this hypothesis 
19S-producing  cells divide and mature, reach a final stage and start to produce 
7S antibodies. The  latter  would inhibit  the  initiation  of new  19S-producing 
cells  through  combination  with  the antigen  and  therefore suppress  the  re- 
cruitment of their own precursors. This would lead to a steady state of 7S pro- 
duction by cells with a long lifetime.  This hypothesis is in agreement with the 
finding that passively transferred antibodies given 5 to 7 days after the anti- 
gen, at a time when 7S production has just started, do not detectably inhibit 
subsequent 7S synthesis. Antiserum given after 3 days caused a  decreased 7S 
production, as would be expected,  since  the  antiserum  caused a  slight  but 
detectable decrease in the number of 19S producing ceils, thereby inhibiting a 
fraction of the 7S precursor cells. According  to  this  hypothesis, therefore, 7S 
antibodies would possess animportant regulatory function and would act in a 
feed-back system preventing extensive cellular multiplication in response to a 
single  antigen, and, therefore, protect against hyperimmunization  and/or ex- 
cessive multiplication of one category of ceils. 
S~RY 
The  suppressing  activity of passively transferred  antibodies  on  antibody 
synthesis against sheep red ceils was investigated at the cellular  level by the 988  ANTIBODY SYNTHESIS AT CELLULAR LEVEL 
agar-plaque technique developed by Jerne. Humoral antibodies injected prior 
to the antigen suppressed the appearance of plaque-formlng spleen cells  pro- 
ducing 19S antibodies completely. Antibodies given during the first 4 days after 
antigen injection also showed such action, but only after a latency period of 40 
hours. The inhibiting efficiency of 7S antibodies was about 100 to  200 times 
greater than that of 19S antibodies. The results support the conclusion  that hu- 
moral antibodies inhibit the immune response by removing the stimulus for the 
proliferation of  the antibody producing cells  and not  by directly depressing 
antibody synthesis in already committed cells. 
Passively transferred antibodies inhibited the 7S response if given prior to, 
or 24 hours after the antigen injection, in analogy with previous results con- 
ceming  19S response.  In contrast to these previous results on 19S synthesis, 
antibody transfer had no detectable effect during the early exponential phase 
of 7S production (5 to 7 days after antigen injection). Only limited inhibition 
was observed 3 days after the antigen. One possible explanation of this differ- 
ence is that 7S-producing  cells do not divide,  or divide at a slow rate. Antigen 
injection would stimulate the proliferation of 19S-producing cells. Subsequently 
these would switch to the synthesis of 7S antibodies. These would inhibit the 
initiation of new 19S-producing cells by combining with the antigen. They would 
thus suppress the recruitment  of their own precursors. A  steady state of ?S 
antibody production by cells with a  long  lifetime  would be the result.  This 
hypothesis ascribes an important  regulatory function to 7S antibodies. They 
would be parts of a feed-back system preventing excessive cell multiplication 
in response to a single antigen. 
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